US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 4.040
  • +0.080+2.02%
Trading Dec 26 11:20 ET
174.41MMarket Cap-1.58P/E (TTM)

About Kyverna Therapeutics Company

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Company Profile

SymbolKYTX
Company NameKyverna Therapeutics
Listing DateFeb 8, 2024
Issue Price22.00
CEOMr. Warner Weston Biddle
MarketNASDAQ
Employees96
Fiscal Year Ends12-31
Address5980 Horton Street,Suite 550
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-925-2492
Websitehttp://www.kyvernatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Warner Weston Biddle
  • Chief Executive Officer and Director
  • --
  • Ryan Jones
  • Chief Financial Officer
  • --
  • Karen Walker
  • Chief Technology Officer
  • 1.08M
  • Dominic Borie, M.D.
  • President, Research and Development
  • --
  • Ian T. Clark
  • Chairman of the Board
  • 306.74K
  • Christi Shaw
  • Director
  • --
  • Dr. Steve Liapis, PhD
  • Independent Director
  • --
  • Dr. Beth C. Seidenberg,M.D.
  • Independent Director
  • 155.05K
  • Daniel K. Spiegelman
  • Independent Director
  • 245.05K
  • Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
  • Independent Director
  • 155.05K
  • Mert Aktar
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data